Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidan Bimin Wan dose-ranging phase II study in seasonal allergic rhinitis
ChiCTR-TRC-12002123Phase 2Completed
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Qidan Bimin Pill in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoints: Change and change rate in nasal symptom score, Ocular symptom score and 4 more. Started Mar 2012; status: completed.
02
Drugs
Qidan Bimin Pill
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR-TRC-12002123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002123.